SPIRIT|CONSORT-SURROGATE (@consort_surr) 's Twitter Profile
SPIRIT|CONSORT-SURROGATE

@consort_surr

Developing consensus-driven SPIRIT & CONSORT extensions for reporting #SurrogateEndpoints. Coordinated from @thesphsu @uofglasgow. Tweeting project info/news.

ID: 1488436848489811973

linkhttps://www.gla.ac.uk/spirit-consort-surrogate calendar_today01-02-2022 09:00:35

221 Tweet

115 Followers

125 Following

SPIRIT|CONSORT-SURROGATE (@consort_surr) 's Twitter Profile Photo

Prof Rod Taylor and Dr anthony Muchai Manyara next to our poster on the new SPIRIT-and CONSORT-Surrogate extensions. If at #ictmc2024 come chat with Rod from 12:30pm on reporting surrogate endpoints, its poster number 213.#surrogateendpoints

Prof Rod Taylor and Dr <a href="/AnthonyManyara_/">anthony Muchai Manyara</a> next to our poster on the new SPIRIT-and CONSORT-Surrogate extensions. If at #ictmc2024 come chat with Rod from 12:30pm on reporting surrogate endpoints, its poster number 213.#surrogateendpoints
JAMA (@jama_current) 's Twitter Profile Photo

This morning at #ICTMC2024 JAMA Editor in Chief Kirsten Bibbins-Domingo JAMA Statistical Editor Roger Lewis Marion Campbell of University of Aberdeen Kathryn Rowan ICNARC Rod Taylor University of Glasgow Provide a #JAMASummit update: Is the Clinical Trials Enterprise Broken? And How Can it be Fixed?

This morning at #ICTMC2024

JAMA Editor in Chief <a href="/KBibbinsDomingo/">Kirsten Bibbins-Domingo</a>
JAMA Statistical Editor Roger Lewis
<a href="/MarionKCampbell/">Marion Campbell</a> of <a href="/aberdeenuni/">University of Aberdeen</a>
Kathryn Rowan <a href="/icnarc/">ICNARC</a>
Rod Taylor <a href="/uofglasgow/">University of Glasgow</a>

Provide a #JAMASummit update: Is the Clinical Trials Enterprise Broken? And How Can it be Fixed?
anthony Muchai Manyara (@anthonymanyara_) 's Twitter Profile Photo

Poster up, number 488. Come view and chat about minimum and ideal sample size in multistakeholder Delphi surveys @ictmc2024 #ICTMC2024

Poster up, number 488. Come view and chat about minimum and ideal sample size in multistakeholder Delphi surveys @ictmc2024 #ICTMC2024
Ash Paul (@pash22) 's Twitter Profile Photo

Bedside implications of the use of surrogate endpoints in solid and haematological cancers: implications for our reliance on PFS, DFS, ORR, MRD and more bmjoncology.bmj.com/content/3/1/e0… via Timothée Olivier, MD et al

SPIRIT|CONSORT-SURROGATE (@consort_surr) 's Twitter Profile Photo

📢🆕 editorial on the SPIRIT and CONSORT surrogate extensions in Journal of Dental Research Sage Journals by Falk Schwendicke and Nick Jakubovics which includes examples of surrogate endpoints in dentistry clinical trials 🔗🔗journals.sagepub.com/doi/10.1177/00…

📢🆕 editorial on the SPIRIT and CONSORT surrogate extensions in <a href="/JDentRes/">Journal of Dental Research</a> <a href="/SageJournals/">Sage Journals</a>  by <a href="/FSchwendicke/">Falk Schwendicke</a> and <a href="/NickJakubovics/">Nick Jakubovics</a> which includes examples of surrogate endpoints in dentistry clinical trials

🔗🔗journals.sagepub.com/doi/10.1177/00…
Marion Campbell (@marionkcampbell) 's Twitter Profile Photo

A few weeks ago the World Health Organization (WHO) published new guidance on best practice for clinical trials. It provides really useful considerations for the design and delivery of a quality trial & the wider trials eco-system 1/6 #MethodologyMonday #101

MRC-NIHR Trials Methodology Research Partnership (@mrcnihrtmrp) 's Twitter Profile Photo

Our next round of recruitment to our MRC TMRP DTP is now open. You can view the full list of fully funded PhD studentships available here mrctmrpdtp.com/current-opport…

StatsCI (@stats_ci) 's Twitter Profile Photo

#ictmc2024 might have been a few weeks ago now, but the learnings have stayed with us. For instance, did you know about the @LIGHTSdatabase ? This fantastic resource compiles methods guidance for a range of topics to search through! Check it out below - lights.science

JAMA (@jama_current) 's Twitter Profile Photo

Editorial from Rod Taylor, anthony Muchai Manyara, Joseph Ross, and Oriana Ciani describes the use of surrogate end points and provides new guidance for reporting studies with surrogate outcomes. #JAMASummit ja.ma/4eYIjLy

Editorial from Rod Taylor, <a href="/AnthonyManyara_/">anthony Muchai Manyara</a>, <a href="/jsross119/">Joseph Ross</a>, and <a href="/OrianaCiani/">Oriana Ciani</a> describes the use of surrogate end points and provides new guidance for reporting studies with surrogate outcomes. #JAMASummit ja.ma/4eYIjLy
Derek Stewart (@derekcstewart) 's Twitter Profile Photo

Five Q&As in 5min for better Patient, Public Involvement with health research on #PPI #Research #TrialsMethodology YouTube youtu.be/HBG6ST-yvrw

SPIRIT|CONSORT-SURROGATE (@consort_surr) 's Twitter Profile Photo

Our last output for this year is this editorial in Journal of Physiotherapy led by Christina Faria on Surrogate endpoints in trials of physiotherapy interventions 📎doi.org/10.1016/j.jphy… 📝 Janaine Polese anthony Muchai Manyara Rod Taylor Oriana Ciani Aline Alvim Scianni

Our last output for this year is this editorial in <a href="/JPhysiother/">Journal of Physiotherapy</a> led by Christina Faria on Surrogate endpoints in trials of physiotherapy interventions 

📎doi.org/10.1016/j.jphy…

📝 Janaine Polese <a href="/AnthonyManyara_/">anthony Muchai Manyara</a>  Rod Taylor <a href="/OrianaCiani/">Oriana Ciani</a> <a href="/AlineScianni/">Aline Alvim Scianni</a>
HeartRhythm (@hrs_journal) 's Twitter Profile Photo

A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology Larisa Tereshchenko, MD, PhD heartrhythmjournal.com/article/S1547-…

JAMA (@jama_current) 's Twitter Profile Photo

Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent. Learn more in this Special Communication. ja.ma/4ilAvEx

Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent. 

Learn more in this Special Communication. ja.ma/4ilAvEx
Gary Collins (@gscollins) 's Twitter Profile Photo

NEW PAPER: Updated CONSORT-2025 for reporting randomised trials is now available in the The BMJ JAMA The Lancet Nature Medicine PLOS Medicine —> bmj.com/content/389/bm… #OpenScience #OpenAccess #transparency #medX #statsX #epiX

NEW PAPER: Updated CONSORT-2025 for reporting randomised trials is now available in the <a href="/bmj_latest/">The BMJ</a> <a href="/JAMA_current/">JAMA</a> <a href="/TheLancet/">The Lancet</a> <a href="/NatureMedicine/">Nature Medicine</a> <a href="/PLOSMedicine/">PLOS Medicine</a> 

—&gt; bmj.com/content/389/bm…

#OpenScience #OpenAccess 
#transparency #medX #statsX #epiX